In October 2021 Univercells Group won the Trends-Tendances prestigious “Deal of the Year” award for our capital increase last year, attracting key investors such as Gamma Biosciences (part of KKR & Co. Inc.), international funds specialized in Global Health, Belgian institutional funds and private investors. Prior to those operations, the group had been restructured via the creation of four specialized affiliates (Univercells Technologies, Exothera, Unizima and Quantoom Biosciences).